- Home
- MTEM vs FBRX Comparison
MTEM vs FBRX Comparison
Compare MTEM & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEM
- FBRX
- Stock Information
- Founded
- MTEM 2001
- FBRX N/A
- Country
- MTEM United States
- FBRX United States
- Employees
- MTEM N/A
- FBRX N/A
- Industry
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- MTEM Health Care
- FBRX Health Care
- Exchange
- MTEM Nasdaq
- FBRX Nasdaq
- Market Cap
- MTEM 9.7M
- FBRX 8.3M
- IPO Year
- MTEM N/A
- FBRX N/A
- Fundamental
- Price
- MTEM $0.35
- FBRX $18.75
- Analyst Decision
- MTEM
- FBRX Strong Buy
- Analyst Count
- MTEM 0
- FBRX 3
- Target Price
- MTEM N/A
- FBRX $77.58
- AVG Volume (30 Days)
- MTEM 15.2M
- FBRX 1.7M
- Earning Date
- MTEM 12-27-2024
- FBRX 11-14-2024
- Dividend Yield
- MTEM N/A
- FBRX N/A
- EPS Growth
- MTEM N/A
- FBRX N/A
- EPS
- MTEM N/A
- FBRX N/A
- Revenue
- MTEM $25,470,000.00
- FBRX N/A
- Revenue This Year
- MTEM N/A
- FBRX N/A
- Revenue Next Year
- MTEM N/A
- FBRX N/A
- P/E Ratio
- MTEM N/A
- FBRX N/A
- Revenue Growth
- MTEM N/A
- FBRX N/A
- 52 Week Low
- MTEM $0.30
- FBRX $4.11
- 52 Week High
- MTEM $4.12
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- MTEM 41.77
- FBRX 52.67
- Support Level
- MTEM $0.34
- FBRX $18.33
- Resistance Level
- MTEM $0.78
- FBRX $24.64
- Average True Range (ATR)
- MTEM 0.07
- FBRX 3.23
- MACD
- MTEM 0.01
- FBRX -0.99
- Stochastic Oscillator
- MTEM 5.00
- FBRX 8.56
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).